This was in contrast to sAPX expression in the stroma, which exhibited marked different time-series and median values of F480/F405 ratios in nHyPer2 and sAPX treatments under HL (Figs. 2c, d). The gene discussed is LPO; the disease is Hodgkins lymphoma.